ETRANACOGENE DEZAPARVOVEC
ETRANACOGENE DEZAPARVOVEC is an active ingredient listed in 1 FDA drug label records from 1 manufacturers marketed mainly as human prescription drug products.
About ETRANACOGENE DEZAPARVOVEC
ETRANACOGENE DEZAPARVOVEC appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from CSL Behring. Approved labelling for these products most frequently references: treatment adults, hemophilia congenital, factor deficiency, prophylaxis therapy, current historical, life-threatening hemorrhage, repeated serious, spontaneous bleeding. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.
Main manufacturers
| Manufacturer | Products | Marketing type |
|---|---|---|
| CSL Behring | 1 | HUMAN PRESCRIPTION DRUG |
FDA drug products containing ETRANACOGENE DEZAPARVOVEC
| Brand name | Manufacturer | Type | Route | Dosage form |
|---|---|---|---|---|
| HEMGENIX | CSL Behring | HUMAN PRESCRIPTION DRUG |
Frequently asked questions
How many FDA drug products contain ETRANACOGENE DEZAPARVOVEC?
1 FDA drug label records list ETRANACOGENE DEZAPARVOVEC as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.
Which companies make ETRANACOGENE DEZAPARVOVEC products?
The manufacturers with the most ETRANACOGENE DEZAPARVOVEC label records are CSL Behring. Generic and brand versions may be produced by different companies.
Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.
This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.